CClinicalTrials.gg
Status unknownNCT02027857EITUpdated Jan 6, 2014

Comparison of the Application in Traumatic Brain Edema Between EIT and Non-invasive ICP Monitoring

An interventional study of EIT monitoring and non-invasive ICP monitoring in Brain Electrical Impedance; and Non-invasive Intracranial Pressure, sponsored by Xijing Hospital. Status unknown at 1 site in China. Open to participants aged 16 Years to 65 Years. Per ClinicalTrials.gov, last updated 2014-01-06.

Sponsored by Xijing Hospital · Not applicable, Interventional, and Diagnostic

The sponsor has not verified this record recently (last verified Jan 2014), so the status shown — last known as Not yet recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
16 Years to 65 Years
Sex
All
01

Study summary

Brain edema is the main reason for the disability and lethality in traumatic brain injury, which is the most difficult part of emergency rescue. Recently, there is no medical equipment to monitor the early brain edema in clinic. We have found that Electrical impedance tomography (EIT) can perform the real-time and bedside monitoring of brain electrical impedance after single-dose mannitol treatment, which may be a new strategy for the surveillance of brain edema. In this study, we would like to compare the application in traumatic brain edema between EIT and Noninvasive intracranial pressure (ICP) monitoring, including the progress of brain edema, the relationship between impedance and ICP, and the improvement for the patients' prognosis. EIT would probably be a new image strategy for the treatment of traumatic brain injury.

02

Conditions studied

  • Brain Electrical Impedance;
  • Non-invasive Intracranial Pressure

Browse trials for

Keywords

  • brain electrical impedance;
  • traumatic brain injury;
  • brain edema;
  • intracranial pressure
03

In context

Brain Edema

92 studies on the registry are indexed under Brain Edema; 21 are open to participants now.

This study's planned enrollment of 60 is close to the median of 55 across 55 interventional studies indexed under Brain Edema.

Browse Brain Edema studies →

Lead sponsor

Xijing Hospital is the lead sponsor of 465 studies on the registry; 157 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
16 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  1. Eligible patients were 16 to 65 years of age with all genders.
  2. The patients had been diagnosed as traumatic brain injury during 24 hours before enrollment, with the confirmation of CT or MRI.
  3. All the patients had provided written informed consent.
  1. The patients were receiving usual inpatient rehabilitation and conservative treatment .

Exclusion criteria

Exclusion Criteria:

  1. The patients with indication of operation during the research should be excluded.
  2. The patients were assessed as unqualified for the study according to the comprehensive evaluation opinion brought forward by the research team.
05

Study design

Phase
Not applicable
Primary purpose
Diagnostic
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Participant, Care provider, Investigator)
Enrollment
60 participants (estimated)

Study arms

  • No intervention
    mannitol empirical therapy

    There would be 20 patients in this group, who would be given mannitol to relieve the brain edema depending on the empirical therapy by doctors.

  • Experimental
    EIT monitoring

    There would be 20 patients in this group, who would be given mannitol to relieve the brain edema depending on the results of Electrical impedance tomography monitoring.

    Device: EIT monitoring

  • Other
    non-invasive ICP monitoring

    There would be 20 patients in this group, who would be given mannitol to relieve the brain edema depending on the results of non-invasive intracranial pressure monitoring.

    Device: non-invasive ICP monitoring

Interventions

  • DeviceEIT monitoring
  • Devicenon-invasive ICP monitoring
06

What researchers measure

Primary outcomes

  1. brain electrical impedance

    After the patients' enrollment, the electrodes would be placed properly and the continuous monitoring of brain impedance just be started.

    Time frame: From the 1st day (enrollment) to the 7th day

Secondary outcomes

  1. Glasgow coma scale(GCS)

    The scale is composed of three tests: eye, verbal and motor responses. The three values separately as well as their sum are considered. The lowest possible GCS (the sum) is 3 (deep coma or death), while the highest is 15 (fully awake person).

    Time frame: on the 0 day of the study

  2. demographic characteristics at baseline

    The demographic data include age, gender, injuries reason, time from injuries, and so on.

    Time frame: on the 0 day of the study

  3. kidney function examination

    There are three main indicators: blood creatinine, urea nitrogen, and uric acid. These indicator are used as a monitor of the kidney safety.

    Time frame: On the 1st day, 3rd day, 5th and 7th day

  4. Physiological and pathological reflex check

    Time frame: on the 1st and 7th day

  5. muscular strength and tension test

    There are 6 grades in muscular strength test. And muscular tension test was referred to Modified Ashworth scale.

    Time frame: on the 1st and 7th day

  6. non-invasive intracranial pressure

    This equipment can continuously monitor the change of intracranial pressure since the patients' enrollment.

    Time frame: From the 1st day (enrollment) to the 7th day

  7. brain CT scan

    Brain CT scan is applied to monitor the degree and progress of the brain change after the medication of mannitol.

    Time frame: On the 1st day (enrollment), and 7th day

  8. Disability Rating Scale (DRS)

    The DRS includes measures of eye opening, verbalization, and motor response (derived from the Glasgow Coma Scale); cognitive understanding of feeding, dressing, and grooming; degree of assistance and supervision required; and employability. Scores range from 0 to 29, with higher values indicating greater disability.

    Time frame: on the 1st day (enrollment), seventh day after hospitalization

  9. glasgow outcome scale(GOS)

    GOS includes 5 grades: Dead, Vegetative state, Severe disability, Moderate disability, Good recovery.

    Time frame: the patients were discharged or the 7th day after hospitalization

07

Study locations

1 site
  • Department of Neurosurgery, Xijing Hospital, Fourth Military Medical University
    Xi'an City, Shaanxi 710032, China
    • Hu Shijie, M.D.,Ph.D. · Contact · hushijie@fmmu.edu.cn · 086-29-84773307
    • Fei Zhou, M.D.,Ph.D. · Contact · feizhou@fmmu.edu.cn · 086-13992888996
    • Hu Shijie, M.D.,Ph.D. · Principal investigator
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 6, 2014, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT02027857
Lead sponsor
Xijing Hospital
Responsible party
Sponsor
First posted
Jan 6, 2014
Start date
Jan 2014
Primary completion
Jan 2015 (estimated)
Completion
Jun 2015 (estimated)
Last update
Jan 6, 2014

Study contacts

Hu Shijie, M.D;Ph.D.
Contact
hushijie@fmmu.edu.cn
086-29-84773307
Hu Shijie, M.D;Ph.D.
Contact
hushijie1979@126.com
086-13992888996
Fei Zhou, M.D.; Ph.D.
study director · Department of Neurosurgery, Xijing Hospital, Fourth Military Medical University

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Jan 2014. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion